Opioid Use Disorder Treatment
Read our Opioid Use Disorder Treatment Report and Recommendations
(Adopted November 2017)
Implementation Tools
Assess your Organization’s Opioid Use Disorder Treatment Readiness
Track Progress With Core Measures
Watch Our Webinar
Background
Drug overdose is the leading cause of accidental health in the United States, driven by opioid addiction. The majority of people with identified substance use disorders do not receive appropriate care or treatment. Barriers to care lie in lack of access, variation in treatment, and because substance use is highly stigmatized. This workgroup met from December 2016 to November 2017, built on the work of the 2016 Washington State Interagency Opioid Working Plan, and developed the following focus areas:
- Access to evidence-based treatment
- Medication treatment: buprenorphine, methadone, naltrexone (e.g., increase geographic reach, increase number of providers)
- Reduction in stigma associated with treatment
- Referral information
- Providers and patients know where to access care
- Accessible inventory of buprenorphine and methadone prescribers
- Referral infrastructure that supports patients and providers
- Integrated behavioral and physical health to support whole-person care
- Treatment of comorbid conditions including multiple substance use, mental illness, and physical health in line with Behavioral Health Integration Report and Recommendations
Supporting Materials
Opioid Use Disorder Treatment Charter and Roster
Workgroup Members
| Name | Title |
Organization |
| Charissa Fotinos, MD (Co-Chair) | Deputy Medical Officer | Health Care Authority |
| Andrew Saxon, MD (Co-Chair) | Director, Center of Excellence in Substance Abuse Treatment and Education (CESATE) | VA Puget Sound Health Care System |
| Jane Ballantyne, MD, FRCA | Professor, Department of Anesthesiology and Pain Medicine | University of Washington School of Medicine |
| Caleb Banta-Green, PhD, MPH, MSW | Senior Scientist | Alcohol and Drug Abuse Institute, University of Washington |
| David Beck, MD | Immediate Past President | Washington Society of Addiction Medicine |
| Ryan Caldeiro, MD | Chief Chemical Dependency Services and Consultative Psychiatry | Kaiser Permanente |
| Mary Catlin, BSN, MPH | Institutional Nurse Consultant | Department of Health |
| Nancy Lawton, MN, ARNP, FNP | President | ARNPs United of Washington State |
| Darin Neven, MD, MS | President and Founder | Consistent Care |
| Richard Ries, MD | Director, Addiction Psychiatry Residency Program | University of Washington |
| John Robinson, MD, SM | Chief Medical Officer | First Choice Health |
| John Roll, PhD | Professor & Vice Dean for Research, Elson S. Floyd College of Medicine | Washington State University |
| Terry Rogers, MD | Medical Director | Lakeside Milam Recovery |
| Vania Rudolf, MD, MPH | Addiction Recovery Services | Swedish Medical Center |
| Mark Stephens | President | Change Management Consulting |
| Milena Stott, LICSW, CDP | Chief Of Inpatient Services | Valley Cities Counseling |